Trevi Therapeutics, Inc. TRVI Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther.
The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, nondeductible expense, other, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, nondeductible expense, other, amount?
- Trevi Therapeutics, Inc. (TRVI) reported effective income tax rate reconciliation, nondeductible expense, other, amount of $3.5K in Q4 2025.
- How has Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, nondeductible expense, other, amount changed year-over-year?
- Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, nondeductible expense, other, amount increased by 193.3% year-over-year, from -$3.75K to $3.5K.